References
- Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. A review. J Reprod Med. 2002;47:173–189.
- Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I–malignancies of the cervix, ovary, vagina and vulva. Cancer. 2004;101:671–681.
- Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7:206–214.
- Zwaans BM, Chancellor MB, Lamb LE. Modeling and treatment of radiation cystitis. Urology. 2016;88:14–21.
- Kanai A, Epperly M, Pearce L, et al. Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells. Am J Physiol Heart Circ Physiol. 2004;286:H13–21.
- Al Awamlh BAH, Lee DJ, Nguyen DP, et al. Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease. Urology. 2015;85:394–400.
- Zwaans BMM, Lamb LE, Bartolone S, et al. Cancer survivorship issues with radiation and hemorrhagic systitis in gynecological malignancies. Int Urol Nephrol. 2018;50:1745–1751.
- Manikandan R, Kumar S, Dorairajan LN. Hemorrhagic cystitis: a challenge to the urologist. Indian J Urol. 2010;26:159–166.
- Sun XY. Shen Nong Ben Cao Jing. Shanghai: Commercial Press; 1955. p. 90.
- Luo TS, Gao MT, Ma FF, et al. Research advances in pharmacological action and clinical application of Periplaneta americana. J Anhui Agric Sci. 2012;40:5933–5935.
- Zhang HC, Geng FN, Shen YM, et al. Research progress of Kangfuxin Ye in pharmacological action and clinical application. Chin J Ethnomed Ethnopharm. 2016;26:57–60.
- Wen QC. Clinical analysis of Kangfuxin Liquid in prevention and treatment of acute radiation injury of oral mucosa reaction. J Clin Med Lit. 2014;1:467.
- Guo YH. Preventive effect of Kangfuxin liquid on perineal skin and mucosa injury in patients with cervical cancer after radiotherapy. Mod Med J China. 2017;19:70–71.
- Wu FF, Du X. Treatment of hemorrhagic cystitis after hematopoietic stem cell transplantation by intravesical instillation of Kangfuxin liquid: a randomized controlled study. Lab Med Clin. 2017;14:2766–2768.
- Sommariva ML, Sandri SD, Ceriani V. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol. 2010;62:145–150.
- Zhu JJ, Shun Y, Guo X, et al. Bioactivity-guided screening of wound-healing active constituents from American cockroach (Periplaneta americana). Molecules. 2018;23:1.
- Perez CA, Breaux S, Bedwinek JM, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. Cancer. 1984;54:235–246.
- Michael JZ, Heather C, Margie H, et al. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localised prostate cancer. J Urol. 2006;176:1415–1419.
- Noordzij JW, Dabhoiwala NF. Hemorrhagic radiation cystitis. Int Urogynecol J. 1993;4:160–167.
- Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int. 2012;109:691–694.